Welcome to the investors section of Adocia

Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.

Adocia hcw conference 2020 from adocia

Latest Press Releases

2020/09/22Adocia announces a Video Conference to Present a Corporate Update Wednesday, September 23rd, 2020
2020/09/08Number of shares and voting rights of ADOCIA as of August 31, 2020

All Press releases

Next events

September 21-25, 2020 EASD 2020, Virtual Event - Event organized by the European Association for the Study of Diabetes

All events

ADOCIA uses cookies for the effective operation of the Site and to monitor and analyze the traffic on the Site.
The information collected through cookies is solely and strictly for ADOCIA, in compliance with the regulation applicable to the protection of personal data. They are never transmitted to third-parties.

Financial

Welcome to the investors section of Adocia

Adocia’s management will present you a Corporate Update Wednesday, September 23rd, 2020

WATCH GÉRARD SOULA INTERVIEW IN BOURSE & VALEURS FRENCH TV